The Straight Version
AbbVie has agreed to buy Apogee Therapeutics for US$10.9 billion, funded with debt, in a deal that represents a 49 percent premium over Apogee's June 18 close.
The UNHINGED Take
THIS IS HOW YOU MAKE A STATEMENT, FOLKS - a massive US$10.9 billion deal that's all about LONG-TERM GAINS, not just some quick cash grab. The fact that it's funded with debt just shows how SERIOUS AbbVie is about making this work. Meanwhile, the little guys are still fighting for scraps, BUT HEY, THAT'S JUST THE WAY THE COOKIE CRUMBLES, RIGHT? It's all about WHO'S GOT THE POWER, and right now, it's AbbVie.
The Bottom Line
CORPORATE POWER MOVE / 10
THIS IS HOW YOU MAKE A STATEMENT, FOLKS - a massive US$10.9 billion deal that's all about LONG-TERM GAINS, not just some quick cash grab.
📣 Copy, Paste, Cause Chaos
THIS IS HOW YOU MAKE A STATEMENT, FOLKS - a massive US$10.9 billion deal that's all about LONG-TERM GAINS, not just some quick cash grab. CORPORATE POWER MOVE / 10 https://hypervision.art/news/br/americas-split-economy-the-boom-and-the-worker #UnhingedWorld
That cursed thumbnail up top? Spat out by HyperVision AI in about 4 seconds. Go make your own monstrosity — ruin someone's feed today. 🔥